Hearing Impairment Treatment & Management

  • Author: Rahul K Shah; Chief Editor: Glenn C Isaacson, MD, FACS, FAAP   more...
 
Updated: Jul 25, 2011
 

Medical Care

Treatment for CHL

Manage CHL due to otitis media or its sequelae with a course of appropriate antibiotics. Patients with serous otitis media for longer than 3 months benefit from myringotomy and removal of the fluid in the middle ear. Ventilation tubes may ultimately be necessary. If the hearing loss continues, amplification with a hearing aid may be needed. Speech therapy is rarely necessary unless the loss is prolonged and cannot be corrected with amplification.

CHL that results from obstruction of the auditory canal because of cerumen or a foreign body should be treated by removing the obstruction.

Treatment for SNHL

SNHL cannot be medically treated.[32] In mild-to-moderate hearing loss, amplification with hearing aids is used to give the child as much auditory input as possible. Speech therapy may be beneficial. If the child requires special schooling, the school should determine how much speech training is routinely part of the school day. Preferential seating and use of FM systems should be discussed with the patient's family and teachers.

In older children and in adults with moderate-to-profound hearing loss, hearing aids may correct up to 40-60 dB. Beyond that, the limiting factor is the physical sound pressure exerted on the tympanic membrane, which becomes painful after a certain threshold. Young children with small ear canals may perceive pain at amplification volumes as low as 10-15 dB. Modern hearing aids can selectively amplify a specified range of frequencies more than others rather than all frequencies equally.

There are 2 main goals of amplification. The first is to provide language. After the hearing aid is fitted by using proper molds, the hearing aid is tested to see how well it matches the goals for loudness at various frequencies. With older children, speech recognition should be part of this testing. For young children, the goal is to optimize auditory input without causing pain. If the hearing aids are painful to use, children will avoid using them. If amplification is successful in providing improved spoken language comprehension without pain, its use in and out of school should be encouraged.

The second goal of amplification is to provide environmental cues. The use of hearing aids helps to connect young children to their environment, helps to maximize auditory language development if it helps them to hear any speech sounds, and uses auditory pathways to the brain, which may prevent the brain from “ignoring” them (as it does in cortically blinded laboratory animals). The ability to hear environmental sounds is important for safety and some general functioning. Important safety cues include car or truck horns, alarms, or even someone yelling “stop.” Functional cues might include class bells, oven timers, doorbells, or someone calling their name loudly.

Older children may choose not to use their hearing aids because they “don’t look cool.” Rather than making this a significant ongoing argument, parents should be reasonable. For example, if their child is succeeding in school, the hearing aids may not offer a substantial language benefit to their child’s functioning. Additionally, the child is likely safe in the classroom, so benefit might be gained by letting the child “win.” If the child prefers not to wear the hearing aids after school, parents should respect this decision if the child is participating in safe activities when he or she does not have increased risk of harm because of missed environmental cues.

There is no medical disadvantage for children choosing to not use hearing aids. In fact, many deaf adults use their hearing aids selectively or not at all because they find the extraneous noises and distortions they hear are more bothersome than helpful. They may decide to use their hearing aids only when they anticipate a particular benefit.

Next

Surgical Care

Some causes of CHL may be managed or aided surgically.

Children with persistent chronic or recurrent otitis media with resultant effusions may benefit from the placement of myringotomy tubes to ventilate the middle-ear space to prevent negative pressure in this area. If otitis results in the destruction or fixation of the ossicles, surgery may improve ossicular function.

Cholesteatoma is a surgical disease.

Bone-anchored hearing aids (BAHAs) may be useful in some patients. Examples are patients with microtia, those with anotia who are awaiting auricular reconstruction, and patients with persistent otorrhea who cannot use a hearing aid.

SNHL cannot be treated with surgical means other than cochlear implantation. Cochlear implantation may be an option in some children, but it should not be mistaken for a cure. Cochlear implants are discussed in the Cochlear implants section below.

Previous
Next

Consultations

Otolaryngologist

Consulting an otolaryngologist is imperative if the child has CHL. An otolaryngologist can provide advice pertaining to medical and potential surgical interventions. Consultation is also recommended if the child has profound SNHL and is a potential candidate for cochlear implants. The otolaryngologist is a crucial member of the multidisciplinary team needed to help patients with profound SNHL.

Specialists in early intervention

Early intervention programs are essential to help parents understand how to raise a deaf child or one hard of hearing. Such programs are also needed to begin discussing and implementing language and/or educational programs.

Audiologist

Consulting an audiologist is essential for evaluating patients for hearing aids and for fitting them.

Geneticist

Consultation with a geneticist is recommended if the cause of deafness may be syndromic or if the family history suggests a hereditary pattern.

Ophthalmologist, nephrologist, cardiologist, or other subspecialty consultants

Consulting these subspecialists is recommended if an identifiable syndrome implicates involvement of the visual, renal, cardiac, or any other organ system (eg, a deaf child with hematuria should see a nephrologist to check for Alport syndrome).

Similarly, if involvement of an organ system is anticipated because a child is diagnosed with a particular syndrome, a specialist may need to be involved (eg, a deaf child may benefit from aggressive ophthalmologic screening for the development of retinitis pigmentosa as in Usher syndrome, or simply because vision is so important to communication that mild losses in visual acuity should be managed promptly).

Occasionally, a specialist may be able to identify abnormalities that may lead to the diagnosis of a specific syndrome that would not be seen without specialized equipment (eg, ophthalmologist for a funduscopic examination or cardiologist for ECG and/or echocardiography).

Because almost any organ system is potentially related to hearing loss, there is no need to consult every subspecialist for each child with hearing loss. As noted earlier, even routine ECG testing for prolonged a QT interval or laboratory testing for the development of nephritis or changes in blood urea nitrogen and creatinine are not recommended universally.

Experts in managing hearing loss

Consult physicians with expertise in caring for patients with hearing loss, if available in your community. Some physicians have developed expertise in the field of deafness and may be available for consultation. They can offer information about associated medical conditions if present, as well as perspective about language and education, use of hearing aids and cochlear implants, and other equipment. The literature is filled with debates about the most appropriate educational venues for children who are deaf or hard of hearing. Many people involved in early intervention are affiliated with a particular program because it matches their personal biases.

Physicians with expertise in deafness may be more neutral. However, there is a clear bias in the literature towards spoken language as the outcome measure defining success, and relatively good literature about the success of an all-sign-language education (even the literature on reading ability can be questioned).

Previous
Proceed to Medication
 
 
Contributor Information and Disclosures
Author

Rahul K Shah  MD, FACS, FAAP, Associate Professor of Otolaryngology and Pediatrics, Medical Director, Peri-operative Services, Children's National Medical Center, George Washington University School of Medicine and Health Sciences; Attending Physician, Department of Otolaryngology, Children's National Medical Center

Rahul K Shah is a member of the following medical societies: Alpha Omega Alpha, American Academy of Otolaryngology-Head and Neck Surgery, American Academy of Pediatrics, American College of Medical Quality, American College of Physician Executives, American College of Surgeons, Massachusetts Medical Society, Phi Beta Kappa, and Triological Society

Disclosure: Nothing to disclose.

Coauthor(s)

Michael Lotke, MD  Pediatric Clinical Educator, Mount Sinai Hospital–Chicago/Sinai Children's Hospital; Assistant Professor, Department of Pediatrics, Rosalind Franklin University of Medicine and Science

Michael Lotke, MD is a member of the following medical societies: American Academy of Pediatrics and American Public Health Association

Disclosure: Nothing to disclose.

Specialty Editor Board

Orval Brown, MD  Director of Otolaryngology Clinic, Professor, Department of Otolaryngology-Head and Neck Surgery, University of Texas Southwestern Medical Center at Dallas

Orval Brown, MD is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Academy of Pediatrics, American Bronchoesophagological Association, American College of Surgeons, American Medical Association, American Society of Pediatric Otolaryngology, Society for Ear, Nose and Throat Advances in Children, and Society of University Otolaryngologists-Head and Neck Surgeons

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

John E McClay, MD  Associate Professor of Pediatric Otolaryngology, Department of Otolaryngology-Head and Neck Surgery, Children's Hospital of Dallas, University of Texas Southwestern Medical School

John E McClay, MD is a member of the following medical societies: American Academy of Otolaryngic Allergy, American Academy of Otolaryngology-Head and Neck Surgery, American College of Surgeons, and American Medical Association

Disclosure: Nothing to disclose.

Paul D Petry, DO, FACOP, FAAP  Consulting Staff, Freeman Pediatric Care, Freeman Health System

Paul D Petry, DO, FACOP, FAAP is a member of the following medical societies: American Academy of Osteopathy, American Academy of Pediatrics, American College of Osteopathic Pediatricians, and American Osteopathic Association

Disclosure: Nothing to disclose.

Chief Editor

Glenn C Isaacson, MD, FACS, FAAP  Professor of Otolaryngology-Head and Neck Surgery and Pediatrics, Temple University School of Medicine

Glenn C Isaacson, MD, FACS, FAAP is a member of the following medical societies: American Academy of Otolaryngology-Head and Neck Surgery, American Academy of Pediatrics, American Bronchoesophagological Association, American College of Surgeons, American Laryngological Rhinological and Otological Society, American Society of Pediatric Otolaryngology, and Society of University Otolaryngologists-Head and Neck Surgeons

Disclosure: Covidien Honoraria Consulting

References
  1. Morton NE. Genetic epidemiology of hearing impairment. Ann N Y Acad Sci. 1991;630:16-31. [Medline].

  2. Erenberg A, Lemons J, Sia C, Trunkel D, Ziring P. Newborn and infant hearing loss: detection and intervention.American Academy of Pediatrics. Task Force on Newborn and Infant Hearing, 1998- 1999. Pediatrics. Feb 1999;103(2):527-30. [Medline].

  3. Johnson JL, White KR, Widen JE, et al. A multicenter evaluation of how many infants with permanent hearing loss pass a two-stage otoacoustic emissions/automated auditory brainstem response newborn hearing screening protocol. Pediatrics. Sep 2005;116(3):663-72. [Medline].

  4. Katbamna B, Crumpton T, Patel DR. Hearing impairment in children. Pediatr Clin North Am. Oct 2008;55(5):1175-88, ix. [Medline].

  5. Kenna MA. Neonatal hearing screening. Pediatr Clin North Am. Apr 2003;50(2):301-13. [Medline].

  6. Kerschner JE. Neonatal hearing screening: to do or not to do. Pediatr Clin North Am. Jun 2004;51(3):725-36, x. [Medline].

  7. Berg AL, Spitzer JB, Towers HM, Bartosiewicz C, Diamond BE. Newborn hearing screening in the NICU: profile of failed auditory brainstem response/passed otoacoustic emission. Pediatrics. Oct 2005;116(4):933-8. [Medline].

  8. Cohn ES, Kelley PM, Fowler TW, et al. Clinical studies of families with hearing loss attributable to mutations in the connexin 26 gene (GJB2/DFNB1). Pediatrics. Mar 1999;103(3):546-50. [Medline].

  9. Joint Committee on Infant Hearing, American Academy of Audiology, American Academy of Pediatrics, American Speech-Language-Hearing Association, and Directors of Speech and Hearing Programs in State Health and Welfare Agencies. Year 2000 position statement: principles and guidelines for early hearing detection and intervention programs. Pediatrics. Oct 2000;106(4):798-817. [Medline].

  10. American Academy of Pediatrics, Joint Committee on Infant Hearing. Year 2007 position statement: Principles and guidelines for early hearing detection and intervention programs. Pediatrics. Oct 2007;120(4):898-921. [Medline].

  11. US Preventive Services Task Force. Universal screening for hearing loss in newborns: US Preventive Services Task Force recommendation statement. Pediatrics. Jul 2008;122(1):143-8. [Medline].

  12. Nelson HD, Bougatsos C, Nygren P. Universal newborn hearing screening: systematic review to update the 2001 US Preventive Services Task Force Recommendation. Pediatrics. Jul 2008;122(1):e266-76. [Medline].

  13. Kennedy CR, McCann DC, Campbell MJ, et al. Language ability after early detection of permanent childhood hearing impairment. N Engl J Med. May 18 2006;354(20):2131-41. [Medline].

  14. Roizen NJ. Etiology of hearing loss in children. Nongenetic causes. Pediatr Clin North Am. Feb 1999;46(1):49-64, x. [Medline].

  15. Shargorodsky J, Curhan SG, Curhan GC, Eavey R. Change in prevalence of hearing loss in US adolescents. JAMA. Aug 18 2010;304(7):772-8. [Medline].

  16. McGee J, Walsh EJ. Cochlear Transduction and the Molecular Basis of Auditory Pathology. In: Cummings Otolaryngology: Head & Neck Surgery. 5th ed. St. Louis, Mo: Mosby; 2010:Chapter 146.

  17. Harrison M, Roush J, Wallace J. Trends in age of identification and intervention in infants with hearing loss. Ear Hear. Feb 2003;24(1):89-95. [Medline].

  18. Hildebrand MS, Husein M, Smith RJH. Cochlear Genetic Sensorineural Hearing Loss. In: Cummings Otolaryngology: Head & Neck Surgery. 5th ed. St. Louis, Mo: Mosby; 2010:Chapter 147.

  19. Marlin S, Garabédian EN, Roger G, et al. Connexin 26 gene mutations in congenitally deaf children: pitfalls for genetic counseling. Arch Otolaryngol Head Neck Surg. Aug 2001;127(8):927-33. [Medline].

  20. Tashiro K, Konishi H, Sano E, Nabeshi H, Yamauchi E, Taniguchi H. Suppression of the ligand-mediated down-regulation of epidermal growth factor receptor by Ymer, a novel tyrosine-phosphorylated and ubiquitinated protein. J Biol Chem. Aug 25 2006;281(34):24612-22. [Medline].

  21. Modamio-Hoybjor S, Mencia A, Goodyear R, et al. A mutation in CCDC50, a gene encoding an effector of epidermal growth factor-mediated cell signaling, causes progressive hearing loss. Am J Hum Genet. Jun 2007;80(6):1076-89. [Medline]. [Full Text].

  22. Bondurand N, Pingault V, Goerich DE, et al. Interaction among SOX10, PAX3 and MITF, three genes altered in Waardenburg syndrome. Hum Mol Genet. Aug 12 2000;9(13):1907-17. [Medline].

  23. Richardson SO. The child with "delayed speech". Contemp Pediatr. 1992;9(9):55.

  24. Smith RJ, Hone S. Genetic screening for deafness. Pediatr Clin North Am. Apr 2003;50(2):315-29. [Medline].

  25. Genetic Evaluation of Congenital Hearing Loss Expert Panel. Genetics Evaluation Guidelines for the Etiologic Diagnosis of Congenital Hearing Loss. Genetic Evaluation of Congenital Hearing Loss Expert Panel. ACMG statement. Genet Med. May-Jun 2002;4(3):162-71. [Medline].

  26. Choung YH, Moon SK, Park HJ. Functional study of GJB2 in hereditary hearing loss. Laryngoscope. Sep 2002;112(9):1667-71. [Medline].

  27. Gasparini P, Rabionet R, Barbujani G, et al. High carrier frequency of the 35delG deafness mutation in European populations. Genetic Analysis Consortium of GJB2 35delG. Eur J Hum Genet. Jan 2000;8(1):19-23. [Medline].

  28. Green GE, Scott DA, McDonald JM, Woodworth GG, Sheffield VC, Smith RJ. Carrier rates in the midwestern United States for GJB2 mutations causing inherited deafness. JAMA. Jun 16 1999;281(23):2211-6. [Medline].

  29. Parry DA, Booth T, Roland PS. Advantages of magnetic resonance imaging over computed tomography in preoperative evaluation of pediatric cochlear implant candidates. Otol Neurotol. Sep 2005;26(5):976-82. [Medline].

  30. [Guideline] Joint Committee on Infant Hearing. Year 2007 position statement: Principles and guidelines for early hearing detection and intervention programs. Pediatrics. Oct 2007;120(4):898-921. [Medline].

  31. Berlin CI, Morlet T, Hood LJ. Auditory neuropathy/dyssynchrony: its diagnosis and management. Pediatr Clin North Am. Apr 2003;50(2):331-40, vii-viii. [Medline].

  32. Brookhouser PE, Beauchaine KL, Osberger MJ. Management of the child with sensorineural hearing loss. Medical, surgical, hearing aids, cochlear implants. Pediatr Clin North Am. Feb 1999;46(1):121-41. [Medline].

  33. American Academy of Pediatrics Joint Committee on Infant Hearing. Joint Committee on Infant Hearing 1994 Position Statement. Pediatrics. Jan 1995;95(1):152-6. [Medline].

  34. Horn RM, Nozza RJ, Dolitsky JN. Audiological and medical considerations for children with cochlear implants. Am Ann Deaf. Apr 1991;136(2):82-6. [Medline].

Previous
Next
 
Cochlear malformations. Neural foramen on the right is absent. Right arrow indicates a rudimentary vestibule. On the left is a severe cochlear malformation (large arrow). Small arrow indicates the internal auditory canal.
Cochlear implant electrode passing through the facial recess to the scala tympani.
Table. Some Syndromes Associated with Deafness
Organ or SystemSyndromeInheritance PatternHearing LossObvious Physical Abnormalities
External earDiGeorge sequelaeSporadicCHLYes
Branchio-oto-facial syndromeADCHLYes
Townes-Brocks syndromeADSNHLYes
Miller syndromeARCHLYes
Bixler syndromeARCHLYes
CardiacColoboma, heart disease, atresia choanae, retarded growth, and ear anomalies (CHARGE) syndromeAD, AR, X linked, sporadicSNHL, mixedYes
Jervell Lange-Nielson syndromeARSNHLNo
Limb-oto-cardiac syndromeARCHLYes
RenalAlport syndromeAD, AR, X linkedSNHLYes or no
Branchio-oto-renal syndromeADSNHL, CHLYes
Kearns-Sayre syndromeSporadicSNHLYes
Epstein syndromeADSNHLNo
Barakat syndromeARSNHLNo
Mental (retardation)Noonan syndromeSporadicSNHLYes
Killian/Teschler-Nicola syndromeSporadicSNHLYes
Cockayne syndrome, type IARSNHLYes
Gustavson syndromeX linkedSNHLYes
DermatologicWaardenburg syndromeADSNHLYes
Lentigines, ECG, ocular, pulmonary, abnormal, retardation, and deafness (LEOPARD) syndromeADSNHLYes
Senter syndromeARSNHLYes
Black locks with albinism and deafness (BADS) syndromeARSNHLYes
Davenport syndromeARSNHLYes
Endocrine and/or metabolicPendred syndromeARSNHLYes or no
Johanson-Blizzard syndromeARSNHLYes
Refetoff syndromeARSNHLYes
Wolfram syndromeARSNHLYes or no
Kallmann syndromeAD, AR, X linkedSNHL, mixedYes or no
FacialGoldenhar syndromeAD, ARCHL, SNHLYes
Frontometaphyseal dysplasiaX linkedMixedYes
Escher-Hirt syndromeADCHLYes
Levy-Hollister syndromeADSNHLYes
OphthalmologicUsher syndromeARSNHLYes or no
Marshall syndromeADSNHLYes
Alström syndromeARSNHLYes
Harboyan syndromeARSNHLYes or no
Fraser syndromeARCHLYes
Jensen syndromeX linkedSNHLNo
OrthopedicKlippel-Feil sequelaeSporadicCHL, SNHLYes
Stickler syndromeADCHL, SNHL, mixedYes
Craniometaphyseal dysplasiaAD, ARCDYes
Oto-spondylo-megaepiphyseal dysplasia (OSMED) syndromeARSNHLYes
Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.